TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26525880

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 2713

Group type: EXPERIMENTAL
Intervention: Metformin treatment
Number of subjects: 2713

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 2713
Study: 25051779

Group type: EXPERIMENTAL
Intervention: Reamberin in pathogenetic therapy
Number of subjects: 0
Study: 22289227

Group type: EXPERIMENTAL
Intervention: 120-minute therapy sessions involving RTP incorporating the ESN
Number of subjects: 32

Group type: COMPARATOR
Intervention: 30-minute home exercise program
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 60-minute therapy sessions involving RTP incorporating the ESN
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 30-minute therapy sessions involving RTP incorporating the ESN
Number of subjects: 32
Study: 20462826

Group type: EXPERIMENTAL
Intervention: Knowledge of BSE/CBE, marital status, educational status, knowledge of treatment of breast cancer
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: No formal education status, being a farmer
Number of subjects: 386
Study: 18338963

Group type: EXPERIMENTAL
Intervention: Minimal contact physical activity intervention (one group meeting, self-help booklet, five monthly reminder letters)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: International Physical Activity Questionnaire (IPAQ)
Number of subjects: 169
Study: 15805998

Group type: EXPERIMENTAL
Intervention: Allergen challenge
Number of subjects: 10
Study: 12698399

Group type: EXPERIMENTAL
Intervention: Target temperature 28 degrees C
Number of subjects: 30

Group type: COMPARATOR
Intervention: Target temperature 34 degrees C
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Reduction of pump blood flow from 2.4 to 2.0 L/min/m(2) during hypothermia
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Rewarming phase
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Serum concentrations of C3a and IL-6
Number of subjects: 30
Study: 10476890

Group type: EXPERIMENTAL
Intervention: Braun Plak Control Ultra
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Rowenta MH700
Number of subjects: 60
Study: 8760775

Group type: EXPERIMENTAL
Intervention: Controlled-release theophylline
Number of subjects: 18
Study: 1887965

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 60

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 60
Study: 6875530

Group type: EXPERIMENTAL
Intervention: Life skills training
Number of subjects: 28

Group type: COMPARATOR
Intervention: Traditional Veterans Administration rehabilitation program
Number of subjects: 28
Study: 30529836

Group type: EXPERIMENTAL
Intervention: Bottom-up intervention (Brain Fitness)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Top-down intervention (COGPACK)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control condition (Sporcle - commercial computer games)
Number of subjects: 99
Study: 29752001

Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.3 mg
Number of subjects: 666

Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.5 mg
Number of subjects: 666

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 666
Study: 23773886

Group type: EXPERIMENTAL
Intervention: Risperidone Long-Acting Injectable (RLAI)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Oral second-generation antipsychotics (SGAs)
Number of subjects: 85
Study: 23532306

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control
Number of subjects: 34
Study: 22152650

Group type: EXPERIMENTAL
Intervention: HFCS-sweetened beverages
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sucrose-sweetened beverages
Number of subjects: 40
Study: 19013235

Group type: EXPERIMENTAL
Intervention: Weight-loss program (12 weeks) followed by weight stabilization (4 weeks)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Weight maintenance (16 weeks)
Number of subjects: 42
Study: 17161887

Group type: EXPERIMENTAL
Intervention: Standard polymeric diet (Group S, n=8)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Glutamine-enriched polymeric diet (Group G, n=7)
Number of subjects: 15
Study: 15047035

Group type: EXPERIMENTAL
Intervention: Carvedilol (20 mg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Propranolol (60 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normotensive controls (placebo)
Number of subjects: 60
Study: 12501759

Group type: EXPERIMENTAL
Intervention: Zafirlukast 20 mg twice a day for eight weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 20
Study: 9798587

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg keliximab
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 1.5 mg/kg keliximab
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 3.0 mg/kg keliximab
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 7619674

Group type: EXPERIMENTAL
Intervention: Romazarit 200 mg every 12 h for up to 24 weeks
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Romazarit 450 mg every 12 h for up to 24 weeks
Number of subjects: 224

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 224
Study: 2180024

Group type: EXPERIMENTAL
Intervention: Pure strength training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Functional training without specific strength training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New rehabilitation programme combining pure strength training and functional training
Number of subjects: 0
Study: 633026

Group type: EXPERIMENTAL
Intervention: Intermittent phototherapy (15 minutes light on, 15 minutes light off)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intermittent phototherapy (15 minutes light on, 30 minutes light off)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intermittent phototherapy (15 minutes light on, 60 minutes light off)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Continuous illumination
Number of subjects: 0
Study: 31698293

Group type: EXPERIMENTAL
Intervention: Medication error encouragement training (MEET)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Traditional error avoidance training (Control)
Number of subjects: 97
Study: 31424460

Group type: EXPERIMENTAL
Intervention: Adherence and symptom management group
Number of subjects: 272

Group type: COMPARATOR
Intervention: Usual care/control group
Number of subjects: 272
Study: 28720612

Group type: EXPERIMENTAL
Intervention: Prospective clinical team surveillance (PCTS)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: High-fidelity PCTS
Number of subjects: 7
Study: 25728699

Group type: EXPERIMENTAL
Intervention: Structured plaque control (powered tooth brushing and inter-dental cleaning advice)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control (normal dental plaque control regimen)
Number of subjects: 82
Study: 23665965

Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 390
Study: 21937959

Group type: EXPERIMENTAL
Intervention: Crisis Resource Management (CRM) training during a simulated patient crisis
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Basic Life Support plus CRM training
Number of subjects: 4

Group type: COMPARATOR
Intervention: Basic Life Support only
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Crisis Resource Management (CRM) training
Number of subjects: 4
Study: 20137718

Group type: EXPERIMENTAL
Intervention: MSCT and SAA combined group
Number of subjects: 225

Group type: COMPARATOR
Intervention: MSCT group
Number of subjects: 225
Study: 17367478

Group type: EXPERIMENTAL
Intervention: Atovaquone/proguanil (A/P)
Number of subjects: 169
Study: 15280342

Group type: EXPERIMENTAL
Intervention: Computer-based decision aid followed by genetic counseling (n = 106)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Standard one-on-one genetic counseling (n = 105)
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Both interventions (computer and counseling)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Counseling
Number of subjects: 211
Study: 11204586

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: All statins pooled
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: D-dimer
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP)
Number of subjects: 99
Study: 9458824

Group type: EXPERIMENTAL
Intervention: BNP infusion (1, 2, or 4 pmol.kg‐1.min‐1 for 60 min)
Number of subjects: 48
Study: 8058542

Group type: EXPERIMENTAL
Intervention: Intravenous meperidine (0.8 mg/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Submucosal meperidine (0.8 mg/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Intramuscular meperidine (0.8 mg/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Oral meperidine (1.4 mg/kg)
Number of subjects: 10
Study: 2973132

Group type: EXPERIMENTAL
Intervention: HBM clinical intervention administered in the ED
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HBM phone intervention made 1 to 2 days post-ED visit
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both HBM clinical and phone interventions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 28847853

Group type: EXPERIMENTAL
Intervention: Holistic needs assessment (HNA) and care planning by an allied health professional
Number of subjects: 150

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Holistic needs assessment (HNA) and care planning
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Economic analysis
Number of subjects: 150
Study: 28786220

Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy (ADT)
Number of subjects: 1726

Group type: COMPARATOR
Intervention: No androgen deprivation therapy (Control)
Number of subjects: 1726
Study: 27268421

Group type: EXPERIMENTAL
Intervention: Dupilumab 100 mg every 4 weeks
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Dupilumab 200 mg every 2 weeks
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg every 2 weeks
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg once weekly
Number of subjects: 380

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Dupilumab (all doses)
Number of subjects: 380
Study: 24554099

Group type: EXPERIMENTAL
Intervention: Fluoride toothpaste (1100 µg F/g, NaF/SiO2) used three times a day
Number of subjects: 6

Group type: COMPARATOR
Intervention: Non-fluoride toothpaste (negative control)
Number of subjects: 6
Study: 23734260

Group type: EXPERIMENTAL
Intervention: AF-specific management intervention
Number of subjects: 335

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 335
Study: 20583555

Group type: EXPERIMENTAL
Intervention: Cycloferon (an early interferon 1 and 2 inductor)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Standard symptomatic therapy with cycloferon
Number of subjects: 150
Study: 19108494

Group type: EXPERIMENTAL
Intervention: rikkunshito (TJ‐43)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Control
Number of subjects: 142
Study: 16632141

Group type: COMPARATOR
Intervention: Telephone interview
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: Postal survey
Number of subjects: 416
Study: 12818975

Group type: EXPERIMENTAL
Intervention: Bupivacaine 2 mg and fentanyl 12.5 micro g
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Bupivacaine 2 mg and fentanyl 12.5 micro g with morphine 125 micro g
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 60
Study: 11349388

Group type: EXPERIMENTAL
Intervention: Tianeptine 12.5 mg and 37.5 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Mianserin 30 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 9203655

Group type: EXPERIMENTAL
Intervention: Purified recombinant hemagglutinin (rHA) from influenza A/Beijing/32/92 (H3N2) virus
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 0
Study: 7960505

Group type: EXPERIMENTAL
Intervention: Plasma
Number of subjects: 10

Group type: COMPARATOR
Intervention: Synovial fluid
Number of subjects: 10
Study: 2958914

Group type: EXPERIMENTAL
Intervention: 0.08 mg ipratropium bromide
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 0.15 mg ipratropium bromide
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 0.25 mg ipratropium bromide
Number of subjects: 64
Study: 29940902

Group type: EXPERIMENTAL
Intervention: Thirsty? Choose Water! behavioural intervention (TCW‐BI)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Chilled water stations
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both TCW‐BI and chilled water stations
Number of subjects: 60

Group type: COMPARATOR
Intervention: Neither intervention (control group)
Number of subjects: 60
Study: 28033030

Group type: EXPERIMENTAL
Intervention: IVI and KIN
Number of subjects: 56

Group type: COMPARATOR
Intervention: IVI
Number of subjects: 56

Group type: COMPARATOR
Intervention: Math control group
Number of subjects: 56
Study: 26454386

Group type: EXPERIMENTAL
Intervention: Honey dressing (group A)
Number of subjects: 348

Group type: COMPARATOR
Intervention: Normal saline dressing (group B)
Number of subjects: 348
Study: 23293008

Group type: EXPERIMENTAL
Intervention: 14°C Cold-Water Immersion (CWI)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 30°C Warm-Water Immersion (WWI)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Passive Control (CON)
Number of subjects: 12
Study: 21641198

Group type: EXPERIMENTAL
Intervention: 10 IU of oxytocin infused over 30 min (0.33 IU/min) - G1
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 10 IU of oxytocin infused over 3 min and 45 s (2.67 IU/min) - G2
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 80 IU of oxytocin infused over 30 min (2.67 IU/min) - G3
Number of subjects: 30
Study: 18815568

Group type: EXPERIMENTAL
Intervention: Experimental group (n = 11) performed three sets of three-repetition maximum bench presses before throwing
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (n = 12) rested passively for 15 minutes before throwing
Number of subjects: 23
Study: 16466322

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control groups from randomized controlled trials
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Randomized controlled trial assessing propranolol
Number of subjects: 32
Study: 14728498

Group type: EXPERIMENTAL
Intervention: Wireless PDA software for pre-operative patient assessment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control arm (standard assessment without PDA)
Number of subjects: 0
Study: 11191538

Group type: EXPERIMENTAL
Intervention: Non-invasive pressure support ventilation (NIPSV)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional oxygen therapy
Number of subjects: 40
Study: 9169309

Group type: EXPERIMENTAL
Intervention: Reboxetine
Number of subjects: 256

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 256
Study: 31113857

Group type: EXPERIMENTAL
Intervention: Incentive Spirometry (IS)
Number of subjects: 112

Group type: COMPARATOR
Intervention: EzPAP lung expansion therapy
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Both IS and EzPAP
Number of subjects: 112
Study: 29248711

Group type: EXPERIMENTAL
Intervention: Gingival augmentation using CTG (group IIb)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Gingival augmentation using CMX (group IIIb)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group I (without GA)
Number of subjects: 57
Study: 26785092

Group type: EXPERIMENTAL
Intervention: Simulation-based training using live feline model
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Simulation-based training using simulated feline model
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Posttraining assessment at 18 weeks
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Posttraining assessment at 52 weeks
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Experience level in performing pediatric and neonatal intubation
Number of subjects: 171
Study: 24660840

Group type: EXPERIMENTAL
Intervention: RPV+FTC/TDF
Number of subjects: 543

Group type: COMPARATOR
Intervention: EFV+FTC/TDF
Number of subjects: 543
Study: 22526198

Group type: EXPERIMENTAL
Intervention: Taping
Number of subjects: 18

Group type: COMPARATOR
Intervention: Cylinder cast immobilization
Number of subjects: 18
Study: 19274698

Group type: EXPERIMENTAL
Intervention: 4-combination (butterbur root, valerian root, passionflower herb, lemon balm leaf)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: 3-combination (valerian root, passionflower herb, lemon balm leaf)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 182
Study: 16857467

Group type: EXPERIMENTAL
Intervention: Intravenous hydromorphone at 0.015 mg/kg
Number of subjects: 198

Group type: COMPARATOR
Intervention: Intravenous morphine at 0.1 mg/kg
Number of subjects: 198
Study: 15537997

Group type: EXPERIMENTAL
Intervention: Hydrotherapy (20 min of water exercises at 71 degrees F, full immersion, 3 times per week)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Passive range of motion exercise and oral baclofen (control group)
Number of subjects: 20
Study: 11283528

Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy
Number of subjects: 198

Group type: COMPARATOR
Intervention: Open appendectomy
Number of subjects: 198
Study: 9416930

Group type: EXPERIMENTAL
Intervention: 3 mg of morphine administered intravenously (group 1A)
Number of subjects: 38

Group type: COMPARATOR
Intervention: No morphine administered (group 1B)
Number of subjects: 38
Study: 8100189

Group type: EXPERIMENTAL
Intervention: 75 mg of roxatidine acetate twice daily
Number of subjects: 408

Group type: COMPARATOR
Intervention: 150 mg of ranitidine twice daily
Number of subjects: 408
Study: 2892152

Group type: EXPERIMENTAL
Intervention: famotidine
Number of subjects: 14

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 14
Study: 30598522

Group type: EXPERIMENTAL
Intervention: High baseline levels of miR-150
Number of subjects: 462

Group type: EXPERIMENTAL
Intervention: High baseline levels of miR-30a-5p
Number of subjects: 462

Group type: EXPERIMENTAL
Intervention: High levels (T3) of miR-150
Number of subjects: 462

Group type: EXPERIMENTAL
Intervention: High levels (T3) of miR-30a-5p
Number of subjects: 462

Group type: EXPERIMENTAL
Intervention: Low levels (T1) of miR-15a
Number of subjects: 462

Group type: EXPERIMENTAL
Intervention: Low levels (T1) of miR-375
Number of subjects: 462
Study: 27781435

Group type: EXPERIMENTAL
Intervention: Strong beer
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Regular beer
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Nonalcoholic beer
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Soft drink
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Two additional beers (MSt2)
Number of subjects: 18
Study: 25899547

Group type: EXPERIMENTAL
Intervention: Postural stability assessment during different periods of the day (8-10 am, 10-12 am, 1 pm-3 pm, 3 pm-5 pm)
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Assessment of diurnal variation of balance control
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Assessment of knee pain during different periods of the day
Number of subjects: 241
Study: 24402336

Group type: EXPERIMENTAL
Intervention: 0.3% Melaleuca alternifolia essential oil
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 0.5% triclosan
Number of subjects: 15

Group type: COMPARATOR
Intervention: soft soap + propan‐2‐ol
Number of subjects: 15

Group type: COMPARATOR
Intervention: soft soap
Number of subjects: 15
Study: 20067963

Group type: EXPERIMENTAL
Intervention: READY-Girls intervention (n = 43)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Standard care (n = 45)
Number of subjects: 88
Study: 18006327

Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation programme lasting 4 weeks
Number of subjects: 12

Group type: COMPARATOR
Intervention: Postoperative outcomes
Number of subjects: 12
Study: 16837890

Group type: EXPERIMENTAL
Intervention: Actaea or Cimicifuga racemosa extract (CR BNO 1055)
Number of subjects: 400
Study: 12631634

Group type: EXPERIMENTAL
Intervention: PTA and endoprosthesis placement (Hemobahn endoprosthesis, W.L. Gore & Associates)
Number of subjects: 28

Group type: COMPARATOR
Intervention: PTA alone
Number of subjects: 28
Study: 10853403

Group type: EXPERIMENTAL
Intervention: 600 micrograms vaginal misoprostol pre-operatively
Number of subjects: 278

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 278
Study: 9089852

Group type: EXPERIMENTAL
Intervention: meperidine 10 mg
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: morphine 0.15 mg
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: meperidine 10 mg plus morphine 0.15 mg
Number of subjects: 49
Study: 8250107

Group type: COMPARATOR
Intervention: Chloroquine (25 mg/kg for 48 hr)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Clindamycin (5 mg/kg twice a day for five days)
Number of subjects: 80
Study: 3513269

Group type: EXPERIMENTAL
Intervention: Nebulized salbutamol (1 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Clenbuterol (30 micrograms)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (4 ml of normal saline)
Number of subjects: 12
Study: 30106527

Group type: EXPERIMENTAL
Intervention: Two-step 0.454% SnF₂ dentifrice followed by 3% H₂O₂ whitening gel, 1+1 minute sequential brushing (experimental)
Number of subjects: 165

Group type: COMPARATOR
Intervention: 0.76% sodium monofluorophosphate dentifrice (Colgate Cavity Protection), twice daily use (control)
Number of subjects: 165
Study: 28045865

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 50
Study: 26298036

Group type: EXPERIMENTAL
Intervention: Contrast-Enhanced Ultrasound (CEUS)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Sonoelastography (SE)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Systematic Biopsy (SB)
Number of subjects: 52
Study: 23801585

Group type: EXPERIMENTAL
Intervention: Transdermal rotigotine 2 to 16 mg/24 hours (mean dose, 12.8 mg/24 hours)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 172